(Q38131234)

English

Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants

scientific article published on August 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

phase III clinical trial

0 references

maternal health

0 references

1 reference

based on heuristic

inferred from title

human pregnancy

1 reference

based on heuristic

inferred from title

pregnant person

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

invasive disease

1 reference

based on heuristic

inferred from title

Shabir A. Madhi

1

object named as

Shabir A Madhi

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Stephanie J Schrag

4

object named as

Stephanie Schrag

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Ajoke Sobanjo-ter Meulen

6

object named as

Ajoke Sobanjo-Ter Meulen

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

3

object named as

Paul T Heath

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

author name string

Ziyaad Dangor

2

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Alaine Izu

5

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Peter M Dull

7

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

language of work or name

0 references

publication date

1 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

31 Suppl 4

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

D52-7

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Variation in reported neonatal group B streptococcal disease incidence in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Maternal HIV infection and vertical transmission of pathogenic bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Invasive group B streptococcal infection in infants, Malawi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Bacteremia among children admitted to a rural hospital in Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Where do poor women in developing countries give birth? A multi-country analysis of demographic and health survey data

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Effectiveness of maternal influenza immunization in mothers and infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

A review of fetal and infant protection associated with antenatal influenza immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

An update on vaccination against group B streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Group B streptococcal disease in UK and Irish infants younger than 90 days

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Correlation between serum antibody-levels against group B streptococci and gestational age in newborns

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

High burden of invasive Streptococcus agalactiae disease in South African infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

ACIP: Give pertussis vaccine during every pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

ACOG Committee Opinion No. 521: Update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Group B streptococcal disease in infants: a case control study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Antimicrobial resistance among neonatal pathogens in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

The ethics of clinical research in the Third World

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Ethics of HIV trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Vaccines: correlates of vaccine-induced immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Immunological investigation of infants with septicemia or meningitis due to group B Streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Transplacental passage of IgG antibody to group B streptococcus serotype Ia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Antibodies to Capsular Polysaccharides of Group BStreptococcusin Pregnant Canadian Women: Relationship to Colonization Status and Infection in the Neonate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Quantitative determination of immunoglobulin G specific for group B streptococcal beta C protein in human maternal serum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Estimation of the Protective Level of Human IgG Antibody to the Type-Specific Polysaccharide of Group B Streptococcus Type Ia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Properties of human anti-group B streptococcal type III capsular IgG antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

Class specificity of naturally acquired and vaccine-induced antibody to type III group B streptococcal capsular polysaccharide: determination with a radioimmunoprecipitin assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.029

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2013.02.029

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38131234&oldid=2070966433"